Respiratory & Pulmonary Health Updates: mRNA Asthma Therapies, AI-Powered Wearables, IPF Breakthroughs & More

This week’s Respiratory & Pulmonary roundup highlights pivotal developments—from regulatory wins and first-in-class therapies to gene-editing progress, strategic renewals, and FDA clearances. Whether you’re driving biotech strategy, respiratory R&D, or digital health innovation, these updates are essential for staying ahead of the curve in pulmonary care.

💊 GRI Bio reports positive Phase 2a biomarker data in idiopathic pulmonary fibrosis, showing favorable effects on fibrogenesis, fibrolysis, and possible tissue repair.

🧬 Roche receives FDA clearance for its cobas Respiratory 4-flex test—the first respiratory diagnostic using TAGS technology to simultaneously detect SARS-CoV-2, Flu A/B, and RSV.

🚀 Clarametyx secures both Fast Track and QIDP designations under the FDA’s GAIN Act for CMTX-101, advancing its cystic fibrosis pipeline with promising interim results.

🌫️ Asthma Australia renews its 15-year collaboration with Bird Healthcare to promote inhaler spacer education and improve treatment outcomes across communities.

🧫 Beam Therapeutics advances BEAM-302 in alpha-1 antitrypsin deficiency, reporting durable gene correction in 17 patients, with a full update expected in early 2026.

💉 Ethris initiates Phase 2a dosing for ETH47, an intranasal mRNA therapy aimed at reducing viral asthma exacerbations through targeted interferon lambda delivery.

📱 Respiree earns a second FDA clearance for its RS001 wearable, now authorized for home use with plans to integrate artificial intelligence and software-as-a-medical-device capabilities.

📢 Stay Ahead in Respiratory and Pulmonary Health Research!

✅ Like, share, and subscribe for weekly updates on respiratory health breakthroughs

#RespiratoryHealth #PulmonaryCare #LungDisease #IPF #CysticFibrosis #AsthmaCare #GeneTherapy #AATD #mRNAtherapies #MedicalDevices #FDA #HealthcareInnovation #DigitalHealth #LucidQuest #ClinicalTrials #Diagnostics #AIinMedicine #BiotechNews #RespiratoryResearch #Pulmonology #HealthTech

Privacy Preference Center